In mice, PAI-1 protects against cardiac fibrosis during hypertension by inhibiting the urokinase-type plasminogen activator (uPA)-mediated activation of plasminogen (Pg) and limiting plasmin (Pm) generation [25]. Here, PLAU is linked to hypertensive disorder.